Lung Cancer
Research from the United States and Switzerland add new data to lung cancer body of knowledge
Published in Cancer Weekly, October 3rd, 2006
Study 1: The restaging of lung cancer patients after neoadjuvant chemoradiotherapy was discussed.
According to a study from the United States, "The accuracy of restaging in patients with stage IIIa non-small cell lung cancer after neoadjuvant chemoradiotherapy is unknown. A prospective trial of patients with biopsy-proven N2 disease who underwent initial clinical staging with mediastinoscopy, integrated positron emission tomography/computed tomography (PET/CT), and CT. Patients then were clinically restaged by the same imaging techniques 4 to 12 weeks after their...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-10-03)
More Articles from Cancer Weekly
- Colon Cancer
Colon cancer survival could be extended with physical activity - Complementary & Alternative Medicine
Triptolide displayed potent antileukemic activity - Head & Neck Cancer
Head and neck carcinoma staging only slightly improved with addition of PET to CT and MR scanning - Leukemia
Leukemia risk in children with Down syndrome linked to household chemical exposure - Pediatric Radiology
Pediatricians' awareness of radiation protection issues was low - Adenoid Cystic Cancer
Sex cord tumor with annular tubules diagnosed by fine needle aspiration - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
